episode 70

Overcoming the data challenges of AI-driven drug discovery

Data Science Leaders | 36:49 | March 28, 2024

Get new episodes 
in your inbox

Return to podcast home

A human being consists of billions of cells, each with the same genetic code but interacting in a myriad ways that can eventually translate into disease. Understanding and treating that disease is, in essence, a data problem. But how do you unlock that data and how do you change an organization to systematically use that data to improve decision-making and accelerate drug discovery?

In this episode, we speak with Volodimir Olexiouk, Director of Scientific Engagement and Data Science Team Lead at BioLizard, about best practices for overcoming the data challenges for AI-driven drug discovery and combining scientific expertise with data science for augmented intelligence in the life sciences.

Join us as we discuss:

  • The challenges in discerning correlation from causation and integrating domain expertise
  • How bridging expertise gaps and merging data silos in pharmaceutical companies radically improves drug-discovery processes
  • The promise AI holds for swifter and more effective responses to future pandemics

Popular episodes

Ivan Black

AI, ML Director at FINRA

EPISODE 74June 01, 2024

Enabling AI on Enormous Financial Datasets at FINRA

Listen Now | 27:17

Akshaya Murthy

Director, AI Transformation at Zendesk

EPISODE 73May 17, 2024

Developing a Strategy for AI Transformation at Zendesk

Listen Now | 37:42

Featured Guest

Mike Gualtieri, VP and Principal Analyst at Forrester

EPISODE 72May 03, 2024

Surviving and thriving as an AI leader in a Gen AI world

Listen Now | 43:41

See why Fortune 100 data science leaders choose Domino